Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Nadler E, Forsyth M, Satram-Hoang S, Reyes C. Costs and clinical outcomes among patients with second-line non-small cell lung cancer in the outpatient community setting. Journal of Thoracic Oncology 2012; 7(1): 212-218 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Agents /economics /therapeutic use; Carcinoma, Non-Small-Cell Lung /drug therapy /economics; Clinical Laboratory Techniques; Disease-Free Survival; Erlotinib Hydrochloride; Female; Glutamates /economics /therapeutic use; Guanine /analogs & Health Services /utilization; Humans; Kaplan-Meier Estimate; Lung Neoplasms /drug therapy /economics; Male; Middle Aged; Office Visits; Pemetrexed; Proportional Hazards Models; Protein Kinase Inhibitors /economics /therapeutic use; Quinazolines /economics /therapeutic use; Taxoids /economics /therapeutic use; United States; derivatives /economics /therapeutic use AccessionNumber 22012000419 Date bibliographic record published 20/03/2013 |